{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T01:00:36Z","timestamp":1790038836970,"version":"4.0.1"},"reference-count":32,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2025,9,22]],"date-time":"2025-09-22T00:00:00Z","timestamp":1758499200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,9,22]],"date-time":"2025-09-22T00:00:00Z","timestamp":1758499200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"name":"National Key Research and Development Program of China","award":["2021YFA0910100"],"award-info":[{"award-number":["2021YFA0910100"]}]},{"name":"Healthy Zhejiang One Million People Cohort","award":["K-20230085"],"award-info":[{"award-number":["K-20230085"]}]},{"name":"Post-doctoral Innovative Talent Support Program","award":["BX2023375"],"award-info":[{"award-number":["BX2023375"]}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82304946"],"award-info":[{"award-number":["82304946"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82473489"],"award-info":[{"award-number":["82473489"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82403546"],"award-info":[{"award-number":["82403546"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004731","name":"Natural Science Foundation of Zhejiang Province","doi-asserted-by":"publisher","award":["LR21H280001"],"award-info":[{"award-number":["LR21H280001"]}],"id":[{"id":"10.13039\/501100004731","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004731","name":"Natural Science Foundation of Zhejiang Province","doi-asserted-by":"publisher","award":["ZCLQN25H1602"],"award-info":[{"award-number":["ZCLQN25H1602"]}],"id":[{"id":"10.13039\/501100004731","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Medicine and Health Science Fund of Zhejiang Province Health Commission","award":["2025KY047"],"award-info":[{"award-number":["2025KY047"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Gastric Cancer"],"published-print":{"date-parts":[[2025,11]]},"DOI":"10.1007\/s10120-025-01661-3","type":"journal-article","created":{"date-parts":[[2025,9,22]],"date-time":"2025-09-22T11:00:53Z","timestamp":1758538853000},"page":"1170-1181","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Clinical-radiomic prognostic model integrating staging before and after neoadjuvant chemotherapy in gastric cancer: a multicenter retrospective study"],"prefix":"10.1007","volume":"28","author":[{"given":"Yizhou","family":"Wei","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Siwei","family":"Pan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yahan","family":"Tong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guoliang","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mengxuan","family":"Cao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanqiang","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruolan","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weiwei","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qing","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ke","family":"Shen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mengya","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruixin","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jintao","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiancheng","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhiyuan","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiangdong","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Can","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,9,22]]},"reference":[{"issue":"3","key":"1661_CR1","first-page":"229","volume":"74","author":"F Bray","year":"2024","unstructured":"Bray F, Laversanne M, Sung H, Ferlay J, Siegel RL, Soerjomataram I, et al. Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2024;74(3):229\u201363.","journal-title":"CA Cancer J Clin"},{"issue":"3","key":"1661_CR2","doi-asserted-by":"publisher","first-page":"153","DOI":"10.21037\/atm-22-109","volume":"10","author":"C Hu","year":"2022","unstructured":"Hu C, Zhang Y, Xu J, Chen W, Yu P, Wang Y, et al. Prognostic significance of serum tumor marker normalization in the perioperative period for patients with advanced gastric cancer. Ann Transl Med. 2022;10(3):153.","journal-title":"Ann Transl Med"},{"issue":"10251","key":"1661_CR3","doi-asserted-by":"publisher","first-page":"635","DOI":"10.1016\/S0140-6736(20)31288-5","volume":"396","author":"EC Smyth","year":"2020","unstructured":"Smyth EC, Nilsson M, Grabsch HI, van Grieken NC, Lordick F. Gastric cancer. Lancet. 2020;396(10251):635\u201348.","journal-title":"Lancet"},{"issue":"13","key":"1661_CR4","doi-asserted-by":"publisher","first-page":"1715","DOI":"10.1200\/JCO.2010.33.0597","volume":"29","author":"M Ychou","year":"2011","unstructured":"Ychou M, Boige V, Pignon JP, Conroy T, Bouch\u00e9 O, Lebreton G, et al. Perioperative chemotherapy compared with surgery alone for resectable gastroesophageal adenocarcinoma: an FNCLCC and FFCD multicenter phase III trial. J Clin Oncol. 2011;29(13):1715\u201321.","journal-title":"J Clin Oncol"},{"issue":"2","key":"1661_CR5","doi-asserted-by":"publisher","first-page":"167","DOI":"10.6004\/jnccn.2022.0008","volume":"20","author":"JA Ajani","year":"2022","unstructured":"Ajani JA, D\u2019Amico TA, Bentrem DJ, Chao J, Cooke D, Corvera C, et al. Gastric cancer, Version 2.2022, NCCN clinical practice guidelines in oncology. J Natl Compr Cancer Netw. 2022;20(2):167\u201392.","journal-title":"J Natl Compr Cancer Netw"},{"issue":"10","key":"1661_CR6","doi-asserted-by":"publisher","first-page":"1005","DOI":"10.1016\/j.annonc.2022.07.004","volume":"33","author":"F Lordick","year":"2022","unstructured":"Lordick F, Carneiro F, Cascinu S, Fleitas T, Haustermans K, Piessen G, et al. Gastric cancer: ESMO clinical practice guideline for diagnosis, treatment and follow-up. Ann Oncol. 2022;33(10):1005\u201320.","journal-title":"Ann Oncol"},{"issue":"6","key":"1661_CR7","doi-asserted-by":"publisher","first-page":"653","DOI":"10.1002\/bjs.9484","volume":"101","author":"A Tsuburaya","year":"2014","unstructured":"Tsuburaya A, Mizusawa J, Tanaka Y, Fukushima N, Nashimoto A, Sasako M. Neoadjuvant chemotherapy with S-1 and cisplatin followed by D2 gastrectomy with para-aortic lymph node dissection for gastric cancer with extensive lymph node metastasis. Br J Surg. 2014;101(6):653\u201360.","journal-title":"Br J Surg"},{"issue":"8","key":"1661_CR8","doi-asserted-by":"publisher","first-page":"1081","DOI":"10.1016\/S1470-2045(21)00297-7","volume":"22","author":"X Zhang","year":"2021","unstructured":"Zhang X, Liang H, Li Z, Xue Y, Wang Y, Zhou Z, et al. Perioperative or postoperative adjuvant oxaliplatin with S-1 versus adjuvant oxaliplatin with capecitabine in patients with locally advanced gastric or gastro-oesophageal junction adenocarcinoma undergoing D2 gastrectomy (RESOLVE): an open-label, superiority and non-inferiority, phase 3 randomised controlled trial. Lancet Oncol. 2021;22(8):1081\u201392.","journal-title":"Lancet Oncol"},{"issue":"3","key":"1661_CR9","doi-asserted-by":"publisher","first-page":"312","DOI":"10.1016\/S1470-2045(24)00676-4","volume":"26","author":"X Zhang","year":"2025","unstructured":"Zhang X, Liang H, Li Z, Xue Y, Wang Y, Zhou Z, et al. Perioperative or postoperative adjuvant oxaliplatin with S-1 versus adjuvant oxaliplatin with capecitabine in patients with locally advanced gastric or gastro-oesophageal junction adenocarcinoma undergoing D2 gastrectomy (RESOLVE): final report of a randomised, open-label, phase 3 trial. Lancet Oncol. 2025;26(3):312\u20139.","journal-title":"Lancet Oncol"},{"issue":"2","key":"1661_CR10","doi-asserted-by":"publisher","first-page":"212","DOI":"10.1016\/S1470-2045(23)00541-7","volume":"25","author":"K Shitara","year":"2024","unstructured":"Shitara K, Rha SY, Wyrwicz LS, Oshima T, Karaseva N, Osipov M, et al. Neoadjuvant and adjuvant pembrolizumab plus chemotherapy in locally advanced gastric or gastro-oesophageal cancer (KEYNOTE-585): an interim analysis of the multicentre, double-blind, randomised phase 3 study. Lancet Oncol. 2024;25(2):212\u201324.","journal-title":"Lancet Oncol"},{"issue":"17","key":"1661_CR11","doi-asserted-by":"publisher","first-page":"2012","DOI":"10.1200\/JCO.23.01601","volume":"42","author":"YY Janjigian","year":"2024","unstructured":"Janjigian YY, Ajani JA, Moehler M, Shen L, Garrido M, Gallardo C, et al. First-line nivolumab plus chemotherapy for advanced gastric, gastroesophageal junction, and esophageal adenocarcinoma: 3-year follow-up of the phase III CheckMate 649 Trial. J Clin Oncol. 2024;42(17):2012\u201320.","journal-title":"J Clin Oncol"},{"issue":"1","key":"1661_CR12","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1186\/s13045-023-01451-3","volume":"16","author":"WL Guan","year":"2023","unstructured":"Guan WL, He Y, Xu RH. Gastric cancer treatment: recent progress and future perspectives. J Hematol Oncol. 2023;16(1):57.","journal-title":"J Hematol Oncol"},{"issue":"6","key":"1661_CR13","doi-asserted-by":"publisher","first-page":"1039","DOI":"10.1007\/s10120-022-01325-6","volume":"25","author":"HD Kim","year":"2022","unstructured":"Kim HD, Lee JS, Park YS, Yook JH, Noh SH, Park YK, et al. Determinants of clinical outcomes of gastric cancer patients treated with neoadjuvant chemotherapy: a sub-analysis of the PRODIGY study. Gastric Cancer. 2022;25(6):1039\u201349.","journal-title":"Gastric Cancer"},{"issue":"11","key":"1661_CR14","doi-asserted-by":"publisher","first-page":"2680","DOI":"10.1002\/1097-0142(19940601)73:11<2680::AID-CNCR2820731105>3.0.CO;2-C","volume":"73","author":"AM Mandard","year":"1994","unstructured":"Mandard AM, Dalibard F, Mandard JC, Marnay J, Henry-Amar M, Petiot JF, et al. Pathologic assessment of tumor regression after preoperative chemoradiotherapy of esophageal carcinoma. Clinicopathologic correlations. Cancer. 1994;73(11):2680\u20136.","journal-title":"Cancer"},{"issue":"29","key":"1661_CR15","doi-asserted-by":"publisher","first-page":"9850","DOI":"10.3748\/wjg.v20.i29.9850","volume":"20","author":"A Maguire","year":"2014","unstructured":"Maguire A, Sheahan K. Controversies in the pathological assessment of colorectal cancer. World J Gastroenterol. 2014;20(29):9850\u201361.","journal-title":"World J Gastroenterol"},{"issue":"2","key":"1661_CR16","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1007\/s00428-012-1193-3","volume":"460","author":"R Chetty","year":"2012","unstructured":"Chetty R, Gill P, Govender D, Bateman A, Chang HJ, Driman D, et al. A multi-centre pathologist survey on pathological processing and regression grading of colorectal cancer resection specimens treated by neoadjuvant chemoradiation. Virchows Arch. 2012;460(2):151\u20135.","journal-title":"Virchows Arch"},{"issue":"12","key":"1661_CR17","doi-asserted-by":"publisher","first-page":"749","DOI":"10.1038\/nrclinonc.2017.141","volume":"14","author":"P Lambin","year":"2017","unstructured":"Lambin P, Leijenaar RTH, Deist TM, Peerlings J, de Jong EEC, van Timmeren J, et al. Radiomics: the bridge between medical imaging and personalized medicine. Nat Rev Clin Oncol. 2017;14(12):749\u201362.","journal-title":"Nat Rev Clin Oncol"},{"issue":"7","key":"1661_CR18","first-page":"1980","volume":"109","author":"C Hu","year":"2023","unstructured":"Hu C, Chen W, Li F, Zhang Y, Yu P, Yang L, et al. Deep learning radio-clinical signatures for predicting neoadjuvant chemotherapy response and prognosis from pretreatment CT images of locally advanced gastric cancer patients. Int J Surg (London, England). 2023;109(7):1980\u201392.","journal-title":"Int J Surg (London, England)"},{"issue":"8","key":"1661_CR19","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2021.21143","volume":"4","author":"W Wang","year":"2021","unstructured":"Wang W, Peng Y, Feng X, Zhao Y, Seeruttun SR, Zhang J, et al. Development and validation of a computed tomography-based radiomics signature to predict response to neoadjuvant chemotherapy for locally advanced gastric cancer. JAMA Netw Open. 2021;4(8):e2121143.","journal-title":"JAMA Netw Open"},{"issue":"12","key":"1661_CR20","doi-asserted-by":"publisher","first-page":"3683","DOI":"10.1245\/s10434-017-6078-x","volume":"24","author":"H In","year":"2017","unstructured":"In H, Solsky I, Palis B, Langdon-Embry M, Ajani J, Sano T. Validation of the 8th edition of the AJCC TNM staging system for gastric cancer using the National Cancer Database. Ann Surg Oncol. 2017;24(12):3683\u201391.","journal-title":"Ann Surg Oncol"},{"issue":"6","key":"1661_CR21","doi-asserted-by":"publisher","first-page":"e371","DOI":"10.1016\/S2589-7500(21)00065-0","volume":"3","author":"Y Jiang","year":"2021","unstructured":"Jiang Y, Liang X, Han Z, Wang W, Xi S, Li T, et al. Radiographical assessment of tumour stroma and treatment outcomes using deep learning: a retrospective, multicohort study. Lancet Digit Health. 2021;3(6):e371\u201382.","journal-title":"Lancet Digit Health"},{"issue":"2","key":"1661_CR22","doi-asserted-by":"publisher","first-page":"246","DOI":"10.1200\/JCO.2007.11.5352","volume":"26","author":"JS Jeruss","year":"2008","unstructured":"Jeruss JS, Mittendorf EA, Tucker SL, Gonzalez-Angulo AM, Buchholz TA, Sahin AA, et al. Combined use of clinical and pathologic staging variables to define outcomes for breast cancer patients treated with neoadjuvant therapy. J Clin Oncol. 2008;26(2):246\u201352.","journal-title":"J Clin Oncol"},{"issue":"3","key":"1661_CR23","doi-asserted-by":"publisher","first-page":"465","DOI":"10.1007\/s10120-025-01586-x","volume":"28","author":"CM Weng","year":"2025","unstructured":"Weng CM, Zhong Q, Sun YQ, Liu ZY, Ma YB, Zhang ZQ, et al. A novel ypN-TRG staging system for gastric cancer patients after neoadjuvant therapy based on the metro-ticket paradigm: a multicenter and large sample retrospective analysis. Gastric Cancer. 2025;28(3):465\u201377.","journal-title":"Gastric Cancer"},{"key":"1661_CR24","doi-asserted-by":"publisher","first-page":"1185663","DOI":"10.3389\/fonc.2023.1185663","volume":"13","author":"Z HajiEsmailPoor","year":"2023","unstructured":"HajiEsmailPoor Z, Tabnak P, Baradaran B, Pashazadeh F, Aghebati-Maleki L. Diagnostic performance of CT scan-based radiomics for prediction of lymph node metastasis in gastric cancer: a systematic review and meta-analysis. Front Oncol. 2023;13:1185663.","journal-title":"Front Oncol"},{"issue":"11","key":"1661_CR25","doi-asserted-by":"publisher","first-page":"8765","DOI":"10.1007\/s00330-021-07962-2","volume":"31","author":"Q Xu","year":"2021","unstructured":"Xu Q, Sun Z, Li X, Ye C, Zhou C, Zhang L, et al. Advanced gastric cancer: CT radiomics prediction and early detection of downstaging with neoadjuvant chemotherapy. Eur Radiol. 2021;31(11):8765\u201374.","journal-title":"Eur Radiol"},{"issue":"1","key":"1661_CR26","doi-asserted-by":"publisher","first-page":"421","DOI":"10.1245\/s10434-023-14424-0","volume":"31","author":"H Zhong","year":"2024","unstructured":"Zhong H, Wang T, Hou M, Liu X, Tian Y, Cao S, et al. Deep learning radiomics nomogram based on enhanced CT to predict the response of metastatic lymph nodes to neoadjuvant chemotherapy in locally advanced gastric cancer. Ann Surg Oncol. 2024;31(1):421\u201332.","journal-title":"Ann Surg Oncol"},{"key":"1661_CR27","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1016\/j.ijsu.2018.01.008","volume":"51","author":"F Coccolini","year":"2018","unstructured":"Coccolini F, Nardi M, Montori G, Ceresoli M, Celotti A, Cascinu S, et al. Neoadjuvant chemotherapy in advanced gastric and esophago-gastric cancer. Meta-analysis of randomized trials. Int J Surg. 2018;51:120\u20137.","journal-title":"Int J Surg"},{"issue":"1","key":"1661_CR28","doi-asserted-by":"publisher","first-page":"6093","DOI":"10.1038\/s41467-020-19965-6","volume":"11","author":"BK Sah","year":"2020","unstructured":"Sah BK, Zhang B, Zhang H, Li J, Yuan F, Ma T, et al. Neoadjuvant FLOT versus SOX phase II randomized clinical trial for patients with locally advanced gastric cancer. Nat Commun. 2020;11(1):6093.","journal-title":"Nat Commun"},{"issue":"5","key":"1661_CR29","doi-asserted-by":"publisher","first-page":"516","DOI":"10.21147\/j.issn.1000-9604.2018.05.05","volume":"30","author":"K Xue","year":"2018","unstructured":"Xue K, Ying X, Bu Z, Wu A, Li Z, Tang L, et al. Oxaliplatin plus S-1 or capecitabine as neoadjuvant or adjuvant chemotherapy for locally advanced gastric cancer with D2 lymphadenectomy: 5-year follow-up results of a phase II-III randomized trial. Chin J Cancer Res. 2018;30(5):516\u201325.","journal-title":"Chin J Cancer Res"},{"issue":"5","key":"1661_CR30","doi-asserted-by":"publisher","first-page":"542","DOI":"10.1002\/bjs.11928","volume":"108","author":"C Jin","year":"2021","unstructured":"Jin C, Jiang Y, Yu H, Wang W, Li B, Chen C, et al. Deep learning analysis of the primary tumour and the prediction of lymph node metastases in gastric cancer. Br J Surg. 2021;108(5):542\u20139.","journal-title":"Br J Surg"},{"issue":"6","key":"1661_CR31","doi-asserted-by":"publisher","first-page":"1510","DOI":"10.2214\/AJR.20.23255","volume":"216","author":"Y Chen","year":"2021","unstructured":"Chen Y, Xia Y, Tolat PP, Long L, Jiang Z, Huang Z, et al. Comparison of conventional gadoxetate disodium-enhanced MRI features and radiomics signatures with machine learning for diagnosing microvascular invasion. AJR Am J Roentgenol. 2021;216(6):1510\u201320.","journal-title":"AJR Am J Roentgenol"},{"issue":"6","key":"1661_CR32","doi-asserted-by":"publisher","first-page":"3795","DOI":"10.1097\/JS9.0000000000001239","volume":"110","author":"E Abbaspour","year":"2024","unstructured":"Abbaspour E, Karimzadhagh S, Monsef A, Joukar F, Mansour-Ghanaei F, Hassanipour S. Application of radiomics for preoperative prediction of lymph node metastasis in colorectal cancer: a systematic review and meta-analysis. Int J Surg. 2024;110(6):3795\u2013813.","journal-title":"Int J Surg"}],"container-title":["Gastric Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10120-025-01661-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10120-025-01661-3","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10120-025-01661-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T00:04:49Z","timestamp":1790035489000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10120-025-01661-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9,22]]},"references-count":32,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2025,11]]}},"alternative-id":["1661"],"URL":"https:\/\/doi.org\/10.1007\/s10120-025-01661-3","relation":{},"ISSN":["1436-3291","1436-3305"],"issn-type":[{"value":"1436-3291","type":"print"},{"value":"1436-3305","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,9,22]]},"assertion":[{"value":"30 May 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 September 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 September 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare that they have no competing interests.","order":1,"name":"Ethics","label":"Conflict of interest","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All clinical data of patients were collected in line with ethical policies and procedures approved by the Ethics and Indications Committee of Zhejiang Cancer Hospital (Approval No.: IRB-2023-960), Liaoning Cancer Hospital (Approval No.: KY20240503), and First Affiliated Hospital of Wenzhou Medical University (Approval No.: KY-2025-R042). The study also adhered to the STROCSS reporting guidelines.","order":2,"name":"Ethics","label":"Ethics approval and consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The content of this manuscript has not been previously published and is not under consideration for publication elsewhere. All of the authors agree to the content of the paper and their being listed as a co-author of the paper.","order":3,"name":"Ethics","label":"Consent for publication","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This content has been made available to all.","name":"free","label":"Free to read"}]}}